Hugh McMillan
Investigator
Professor, Pediatric Neurology, University of Ottawa
Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario
NMD4C Involvement: Pillar 2: Clinical Research
Email HughBiography
Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa. He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute
He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook. He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.
Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.
Recent Publications
Guridi, M, De Ford, C, See, CG, Murphy, AP, Chen, Y, Scharke, M et al.. Assessing biomarkers of bone metabolism and the role of the interleukin-6 signaling pathway in patients with Duchenne muscular dystrophy. Neuromuscul Disord. 2026.62 106414 PMID:41894885
Sbrocchi, AM, Kinnett, K, Lautatzis, ME, McMillan, HJ, Selby, KA, Veerapandiyan, A et al.. Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone. J Endocr Soc. 2026.10 (2)bvaf181 PMID:41509125
Ahmadiharchegani, F, Tobin, RA, Degan, C, Naveed, A, Guglieri, M, Jiménez-Requena, A et al.. Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients. Sci Rep. 2025.15 (1)39997 PMID:41238663
Proud, CM, Kichula, EA, Matesanz, SE, Kumar, A, Saito, K, Laverty, CG et al.. Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations. J Neuromuscul Dis. 2025. 22143602251391258 PMID:41212681
Dussah, N, McKim, DA, Mah, JK, McMillan, HJ, Campbell, C, Bijelić, V et al.. Patterns of Adherence to Lung Volume Recruitment Therapy Amongst Individuals With Duchenne Muscular Dystrophy: A Secondary Analysis of the STEADFAST Randomized Controlled Trial. Pediatr Pulmonol. 2025.60 (10)e71357 PMID:41147267
See more on PubMed